These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32708274)

  • 1. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.
    Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of plasma-derived exosomes into CD3
    Theodoraki MN; Hoffmann TK; Whiteside TL
    Clin Exp Immunol; 2018 Jun; 192(3):271-283. PubMed ID: 29431869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer.
    Hofmann L; Medyany V; Ezić J; Lotfi R; Niesler B; Röth R; Engelhardt D; Laban S; Schuler PJ; Hoffmann TK; Brunner C; Jackson EK; Theodoraki MN
    Front Med (Lausanne); 2022; 9():904295. PubMed ID: 35899209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.
    Muller L; Mitsuhashi M; Simms P; Gooding WE; Whiteside TL
    Sci Rep; 2016 Feb; 6():20254. PubMed ID: 26842680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
    Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
    Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
    Theodoraki MN; Yerneni S; Gooding WE; Ohr J; Clump DA; Bauman JE; Ferris RL; Whiteside TL
    Oncoimmunology; 2019; 8(7):1593805. PubMed ID: 31143513
    [No Abstract]   [Full Text] [Related]  

  • 7. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.
    Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL
    Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms.
    Muller L; Simms P; Hong CS; Nishimura MI; Jackson EK; Watkins SC; Whiteside TL
    Oncoimmunology; 2017; 6(8):e1261243. PubMed ID: 28919985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
    Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP.
    Coray M; Göldi V; Schmid L; Benecke L; Figueiró F; Muller L
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology.
    Whiteside TL; Diergaarde B; Hong CS
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of PD-L1
    Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
    Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling of Tumor-Derived sEV Impacts Melanoma Progression.
    Zebrowska A; Widlak P; Whiteside T; Pietrowska M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.
    Ludwig S; Floros T; Theodoraki MN; Hong CS; Jackson EK; Lang S; Whiteside TL
    Clin Cancer Res; 2017 Aug; 23(16):4843-4854. PubMed ID: 28400428
    [No Abstract]   [Full Text] [Related]  

  • 15. Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
    Ludwig N; Gillespie DG; Reichert TE; Jackson EK; Whiteside TL
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived exosomes promote angiogenesis via adenosine A
    Ludwig N; Yerneni SS; Azambuja JH; Gillespie DG; Menshikova EV; Jackson EK; Whiteside TL
    Angiogenesis; 2020 Nov; 23(4):599-610. PubMed ID: 32419057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exosomes: potential liquid biopsy in head and neck cancer].
    Theodoraki MN; Ludwig S
    HNO; 2020 Feb; 68(2):106-110. PubMed ID: 31915880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8⁺ cell-derived exosomes.
    Nazimek K; Ptak W; Nowak B; Ptak M; Askenase PW; Bryniarski K
    Immunology; 2015 Sep; 146(1):23-32. PubMed ID: 25808106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
    Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt?
    Kunigelis KE; Graner MW
    Vaccines (Basel); 2015 Dec; 3(4):1019-51. PubMed ID: 26694473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.